Pure Global AI
Czech Republic flag

Czech Republic medical device registration timeline

Source-linked clocks

State Institute for Drug Control (SÚKL) review clocks and end-to-end planning ranges, using the 4-class (I, IIa, IIb, III) — EU MDR classification system.

1 pathways1 of 1 clocks verifiedvalidity 5 years (CE certificate)MDSAP not acceptedreviewed 2026-08-29eur-lex.europa.eu
Class / pathwayReview clockPlanning totalWith prior approvalProvenance
Class I(Self-declaration (no notified body))
MDR Art. 52(7): non-sterile, non-measuring, non-reusable-surgical Class I devices are self-declared, so no authority or notified body reviews the file and there is no review clock
0 days6-9 monthsVerified
Review clocks exclude applicant hold time · planning totals are estimates

Czech Republic Medical Device Registration Process

Step-by-step SÚKL registration process. Total estimated timeline: 6-9 months.

Step 1: Pre-Submission Preparation

1-3 months

Gather technical documentation, quality management system (QMS) records, and clinical data required by SÚKL. Appoint a EU Authorized Representative.

Step 2: Application Submission

1-2 weeks

Submit complete registration dossier to SÚKL including device description, risk analysis, and testing reports.

Step 3: Administrative Review

2-4 weeks

SÚKL reviews application for completeness. May request additional documents or clarifications.

Step 4: Technical Evaluation

0 days

In-depth technical assessment of device safety and performance. SÚKL may issue questions.

Step 5: Registration Approval

1-2 weeks

Upon successful review, SÚKL issues Czech Republic market authorization certificate.

Summary: The Czech Republic medical device registration process through State Institute for Drug Control (SÚKL) consists of 5 main steps: Pre-Submission Preparation → Application Submission → Administrative Review → Technical Evaluation → Registration Approval.
Prior approval recognition
FDA 510(k)/PMANo substitute for EU MDR conformity assessment; useful as predicate documentation in the technical file
Key requirements
  • EU Authorized Representative (for non-EU manufacturers)
  • Clinical investigation authorisation per MDR Art. 70(7)(b)/IVDR 66(7)(b); investigation cannot start without authorisation and must start within 1 year (§ 20(5) Law 375/2022)
  • Art. 82 investigations notified 60 days before start; may start after 60 days, latest within 1 year (§ 22(3))
  • ISZP annual confirmation within 1 year (reminder 30 days before; restoration within 6 months) (§ 25(2)); custom-made manufacturers notify 30 days before start, generic device groups 6 months (§ 8(4))
  • Fee call within 15 days; non-payment stops the proceedings (UST-29)
Primary regulator sources

Reviewed 2026-08-29. End-to-end totals remain planning estimates.

Keep researching this market
View the Czech Republic resource hub →
Compare timeline across all countries →
Source-linked review clocks verified against SÚKL publications · full review 2026-08-29 · row IDs are stable — cite as registration-timeline:czech-republic:class-i